Prostate cancer recurrence after Focal Therapy: Treatment options

Focal therapy is a novel treatment option in localised prostate cancer with or without a visible lesion on MRI. Treatment for low to intermediate risk prostate cancer with focal therapy has demonstrated good short to medium term outcomes with fewer undesirable genitourinary side effects. This has made focal therapy more appealing to men who find the implications of radical treatment unacceptable or are unable to tolerate active surveillance. In this paper we review the literature for treatment options in prostate cancer recurrence post focal therapy. We also cover the different definitions of failure agreed upon in previous consensus meetings, as well as their implications on future management focal therapy patients.

Archivos espanoles de urologia. 2016 Jul [Epub]

S Hamid, S Guillaumier, T Shah, M Arya, H U Ahmed

Division of Surgery and Interventional Science. Urology Research Group, UCL. London. UK. Department of Urology. UCLH NHS Foundation Trust. London. UK., Division of Surgery and Interventional Science. Urology Research Group, UCL. London. UK. Department of Urology. UCLH NHS Foundation Trust. London. UK., Division of Surgery and Interventional Science. Urology Research Group, UCL. London. UK. Department of Urology. Whittington Hospital NHS Trust. London. UK., Department of Urology. Whittington Hospital NHS Trust. London. UK., Division of Surgery and Interventional Science. Urology Research Group, UCL. London. UK. Department of Urology. UCLH NHS Foundation Trust. London. UK.